Invention Grant
- Patent Title: Glucopyranosyl derivative and use thereof
-
Application No.: US16960488Application Date: 2019-01-22
-
Publication No.: US11084842B2Publication Date: 2021-08-10
- Inventor: Zheng Gu , Wuyong Wu , Tong Qu , Panpan Kang , Zongyuan Zhang , Weiming Huang , Jianyu Liu , Yingjun Zhang
- Applicant: SUNSHINE LAKE PHARMA CO., LTD.
- Applicant Address: CN Guangdong
- Assignee: SUNSHINE LAKE PHARMA CO., LTD.
- Current Assignee: SUNSHINE LAKE PHARMA CO., LTD.
- Current Assignee Address: CN Guangdong
- Agency: Oliff PLC
- Priority: CN201810063061.0 20180123
- International Application: PCT/CN2019/072666 WO 20190122
- International Announcement: WO2019/144864 WO 20190801
- Main IPC: C07H7/04
- IPC: C07H7/04 ; C07H15/207
Abstract:
A glucopyranosyl derivative as a sodium-dependent glucose transporters inhibitor, especially as a SGLT1 inhibitor, a pharmaceutically acceptable salt or a stereoisomer thereof, a pharmaceutical composition thereof, and the uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.
Public/Granted literature
- US20210061839A1 GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF Public/Granted day:2021-03-04
Information query
